一种类似轮充电系统的对比剂用于MRI引导的STING通路激活的癌症免疫疗法
Bin Ren1, Sihua Yan2, Zongheng Li1
1School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Guangzhou, Guangdong, 510515, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 3, 2024
概括
这项研究介绍了Turbo S,这是一种结合MRI对比剂和癌症免疫治疗的STING激动剂的新型纳米粒子. 图尔博S显示增强瘤向和治疗疗效,并提高了安全性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症免疫疗法癌症免疫疗法
背景情况:
- 基于加多的对比剂 (GBCA) 带来了毒性和脑沉积等风险.
- 干扰素基因刺激剂 (STING) 激动剂在稳定性,传递性和毒性方面面临挑战.
- 目前的癌症免疫疗法需要改进向性治疗和有效性.
研究的目的:
- 设计和建造一种用于MRI导向癌症免疫治疗的新型纳米粒子系统.
- 克服现有的GBCA和STING激动剂的局限性.
- 评估开发的系统在瘤治疗中的有效性和生物安全性.
主要方法:
- 使用Poly (?? 烯酸) 和Gd3+形成Gd/PAA宏酸.
- 将Gd/PAA和SR717 (STING激动剂) 与囊胺 (CA) 结合,以创建自组装的纳米粒子 (Turbo S).
- 在体外和体内对Turbo S进行MRI成像,药物释放,瘤向和治疗疗效的评估.
主要成果:
- 图尔博S纳米颗粒证明了高效的瘤积累和内部化.
- 发布的Gd/PAA显示了强大的T1成像能力,具有高的r1值.
- 与高剂量无SR717相比,低剂量的Turbo S获得了优异的瘤免疫治疗疗效.
- 该系统表现出卓越的输送效率,瘤治疗效率和生物安全性.
结论:
- 开发的Turbo S系统为MRI导向的癌症免疫疗法提供了一个有前途的方法.
- 波S有效地解决了传统GBCA和STING激动剂的局限性.
- 这种纳米粒子系统具有增强瘤治疗和改善患者治疗结果的潜力.
相关概念视频
Tumor Immunotherapy
484
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484
Magnetic Resonance Imaging
5.0K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.0K


